olipudase alfa

Active substance     olipudase alfa
Holder     Sanofi
Status Running
Indication acid sphingomyelinase deficiency for patients who have participated and exit the clinical studies DFI-12712-ASCEND or LTS-13632
Public documents Approbation
  Information for the patient
  Informed consent
Last update 29/09/2021

 

Last updated on 21/10/2021